423 related articles for article (PubMed ID: 33941517)
1. Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
Liang T; Yang X; Li R; Yang E; Wang Q; Osherov N; Chen W; Wan Z; Liu W
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0026321. PubMed ID: 33941517
[TBL] [Abstract][Full Text] [Related]
2. Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1.
Handelman M; Morogovsky A; Liu W; Ben-Ami R; Osherov N
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0108921. PubMed ID: 34280014
[TBL] [Abstract][Full Text] [Related]
3. Mutations in
Rybak JM; Ge W; Wiederhold NP; Parker JE; Kelly SL; Rogers PD; Fortwendel JR
mBio; 2019 Apr; 10(2):. PubMed ID: 30940706
[No Abstract] [Full Text] [Related]
4.
Souza ACO; Ge W; Wiederhold NP; Rybak JM; Fortwendel JR; Rogers PD
Microbiol Spectr; 2023 Jun; 11(3):e0518822. PubMed ID: 37140376
[TBL] [Abstract][Full Text] [Related]
5. Hmg1 mutations in Aspergillus fumigatus and their contribution to triazole susceptibility.
Arai T; Umeyama T; Majima H; Inukai T; Watanabe A; Miyazaki Y; Kamei K
Med Mycol; 2021 Oct; 59(10):980-984. PubMed ID: 34019670
[TBL] [Abstract][Full Text] [Related]
6. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
[TBL] [Abstract][Full Text] [Related]
7. Triazole-resistant
Wang Q; Li Y; Li Y; Osherov N; Goldman GH; Verweij PE; Zheng B; Li R; Chen W; Liang T; Wan Z; Liu W
Emerg Microbes Infect; 2022 Dec; 11(1):1435-1438. PubMed ID: 35536092
[No Abstract] [Full Text] [Related]
8. Emergence of Echinocandin Resistance Due to a Point Mutation in the
Jiménez-Ortigosa C; Moore C; Denning DW; Perlin DS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923871
[TBL] [Abstract][Full Text] [Related]
9. A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1.
Rybak JM; Xie J; Martin-Vicente A; Guruceaga X; Thorn HI; Nywening AV; Ge W; Souza ACO; Shetty AC; McCracken C; Bruno VM; Parker JE; Kelly SL; Snell HM; Cuomo CA; Rogers PD; Fortwendel JR
Nat Commun; 2024 Apr; 15(1):3642. PubMed ID: 38684680
[TBL] [Abstract][Full Text] [Related]
10. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
11. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
[TBL] [Abstract][Full Text] [Related]
12. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
[TBL] [Abstract][Full Text] [Related]
13. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
14. Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
Atamna A; Yeshurun M; Shargian L; Raanani P; Kramer M; Ben Zvi H; Ben Ami R; Marr KA; Bishara J
J Antimicrob Chemother; 2024 May; 79(5):1191-1192. PubMed ID: 38334380
[No Abstract] [Full Text] [Related]
15. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
Pelaez T; Gijón P; Bunsow E; Bouza E; Sánchez-Yebra W; Valerio M; Gama B; Cuenca-Estrella M; Mellado E
J Clin Microbiol; 2012 Jul; 50(7):2531-4. PubMed ID: 22573589
[TBL] [Abstract][Full Text] [Related]
16. Emergence of Triazole Resistance in
Yu S; Wang Y; Shen F; Wu R; Cao D; Yu Y
J Agric Food Chem; 2021 Dec; 69(51):15538-15543. PubMed ID: 34915705
[TBL] [Abstract][Full Text] [Related]
17. Triazole Resistance in
Zhang M; Feng CL; Chen F; He Q; Su X; Shi Y
Chin Med J (Engl); 2017 Mar; 130(6):665-668. PubMed ID: 28303848
[TBL] [Abstract][Full Text] [Related]
18. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.
Denning DW; Park S; Lass-Florl C; Fraczek MG; Kirwan M; Gore R; Smith J; Bueid A; Moore CB; Bowyer P; Perlin DS
Clin Infect Dis; 2011 May; 52(9):1123-9. PubMed ID: 21467016
[TBL] [Abstract][Full Text] [Related]
19. Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.
Tashiro M; Izumikawa K; Hirano K; Ide S; Mihara T; Hosogaya N; Takazono T; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yamamoto Y; Yanagihara K; Yasuoka A; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2012 Sep; 56(9):4870-5. PubMed ID: 22751542
[TBL] [Abstract][Full Text] [Related]
20. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Xu J; Sharma C; Sundar G; Singh PK; Gaur SN; Hagen F; Klaassen CH; Meis JF
PLoS One; 2012; 7(12):e52871. PubMed ID: 23285210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
